Plexus (PLXS) is down about 3% in the latest session as investors trim risk ahead of the company’s next earnings catalyst. The company is expected to report fiscal Q2 2026 results after the market close on April 22, 2026, followed by a conference call on April 23 at 8:30 a.m. ET—timing that often triggers positioning and profit-taking in stocks that have rallied into the event. (marketbeat.com)

The stock recently traded near its 52-week high, which can amplify downside moves on quiet news days as short-term holders lock in gains and options markets reprice event risk. With Plexus already valued at a premium multiple versus many contract manufacturing peers, investors may be waiting for fresh confirmation on revenue growth, margin trajectory, and demand visibility before paying up further. (marketbeat.com)

For the upcoming quarter, Wall Street expectations center on roughly $1.88 in EPS and about $1.1309 billion in revenue, while management’s prior guidance called for $1.80–$1.95 in EPS. Traders will likely focus on any commentary around program ramp timing, supply chain conditions, and customer demand stability—especially if the company’s outlook implies a different growth or margin cadence than the market is currently pricing in. (marketbeat.com)

In the most recently reported quarter (released January 28, 2026), Plexus posted EPS of $1.78 on revenue around $1.07 billion, with revenue up about 9.6% year over year. That solid baseline is supporting bullish longer-term views, but it also raises the bar for near-term execution, making the stock more prone to pre-earnings volatility. (marketbeat.com)